Just 1 in 10 common treatments for back pain appear to be effective

Publicly released:
Australia; International; NSW
Photo by Benjamin Wedemeyer on Unsplash
Photo by Benjamin Wedemeyer on Unsplash

Only one in ten common non-surgical and non-invasive treatments for lower back pain are effective, according to Australian and international researchers who re-analysed the data from 301 previous studies assessing 56 common treatments. Non-steroidal anti-inflammatory drugs (NSAIDs), opioids, acupuncture and laser and light therapy were among the treatments most commonly studied. The researchers say that, for acute back pain, only NSAIDs were effective, with exercise, steroids and paracetamol ineffective. For chronic back pain, exercise, spinal manipulation, and taping, antidepressants and drugs that target pain receptors were effective, although only mildly, while anaesthetics and antibiotics were ineffective. The evidence was inconclusive for many of the treatments studied, the researchers say, highlighting the lack of high-quality studies backing up many of the treatments back pain patients are given.

Media release

From: BMJ Group

Only around 1 in 10 common non-surgical and non-invasive treatments for back pain effective

And pain relief only marginally better than placebo, pooled data analysis shows

Only around 1 in 10 common non-surgical and non-invasive treatments for lower back pain is effective, suggests a pooled data analysis of the available research, published online in BMJ Evidence Based Medicine.

And the pain relief they offer is only marginally better than that achieved with a placebo, the findings indicate.

Low back pain is common and debilitating, and 80%-90% of it is categorised as non-specific, because there’s no immediately identifiable cause, note the researchers.

Non-surgical and non-invasive approaches are recommended as the initial treatment approach. But many such options are available, and it’s not always easy to know which ones are effective, point out the researchers.

To build on the evidence base, the researchers scoured research databases for published randomised placebo-controlled trials of non-surgical and non-interventional treatments for people with non-specific low back pain, with the aim of pooling the results.

The approaches included were pharmacological, such as non-steroidal anti-inflammatory drugs (NSAIDs) and muscle relaxants, and non-pharmacological, such as exercise, massage, and spinal manipulation.

A total of 301 trials investigating 56 different treatments or treatment combinations were included in the pooled data analysis. The trials were carried out in a total of 44 countries in Africa, North America, South America, Asia, Australia, and Europe.

The most common interventions were NSAIDs (27 trials), opioids (26 trials), laser and light therapy (25), acupuncture (24), and gentle manual therapy (mobilisation; 19 trials).

Fifty two trials sampled participants with acute low back pain; 228 trials with chronic low back pain; and 21 trials participants with both types. Pain intensity was most often assessed using the Visual Analogue Scale or the Numeric Rating Scale.

Of the 69 treatment comparisons included in the trials, the certainty of the evidence was moderate for 11 (16%), low for 25 (36%), and very low for 33 (48%), as assessed by the GRADE system.

The pooled data analysis showed that compared with placebo, no non-pharmacological treatments and only NSAIDs emerged as effective for acute low back pain; exercise, spinal manipulation, and taping, antidepressants and drugs that target pain receptors (TRPV1 agonists) emerged as effective for chronic low back pain.

But the effects were small.

Moderate quality evidence showed that treatments for acute low back pain that weren’t effective included exercise, steroid injections and paracetamol, while anaesthetics (i.e. Lidocaine) and antibiotics weren’t effective for chronic low back pain, the analysis showed.

The evidence was inconclusive for 10 non-pharmacological and 10 pharmacological treatments for acute low back pain. It was also inconclusive for a wide range of 22 non-pharmacological treatments, including acupuncture, massage, osteopathy and TENS, and 16 pharmacological treatments, including antidepressants + paracetamol, complementary medicines, bisphosphonates, and muscle relaxants for chronic back pain.
The researchers point out that many of the available trials included only a few participants and reported inconsistent results, added to which, the type and quality of some of the placebos used varied considerably, potentially affecting the certainty of the findings.

But they say: “Our review did not find reliable evidence of large effects for any of the included treatments, which is consistent with clinical guidelines and our previous review. While we would like to provide more certain recommendations for where to invest and disinvest in treatments, it is not possible at this time.”  

They emphasise: “There is a clear need for large, high-quality, placebo-controlled trials to reduce uncertainty in efficacy estimates for many non-surgical and non-interventional treatments.”

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research BMJ Group, Web page The URL will go live after the embargo ends
Journal/
conference:
BMJ Evidence-Based Medicine
Research:Paper
Organisation/s: Neuroscience Research Australia (NeuRA), The University of New South Wales, The University of Sydney
Funder: This research received no specific grant from any funding agency in the public, commercial, or not-for- profit sectors. AMH’s start-up award from Memorial University of Newfoundland provided partial funding support for research assistance for this review. AGC is supported by an Australian Government National Health and Medical Research Council Investigator Grant. BF is supported by Newfoundland and Labrador Support for People and Patient-Oriented Research and Trials (NL SUPPORT), the Office of Research and Graduate Studies (Medicine) at Memorial University of Newfoundland, and the Canadian Institute of Health Research, grant number 398 527.
Media Contact/s
Contact details are only visible to registered journalists.